MyLife Technologies is located in Leiden, Netherlands on Robert Boyleweg. MyLife Technologies is rated 3 out of 5 in the category pharmaceutical company in Netherlands. MyLife Technologies is a spin-off company from University of Twente, The Netherlands, developing a unique technology based on ceramic nanoporous MicroNeedle Arrays (npMNA). This npMNA platform technology can be used for dermal drug delivery of among others vaccines, peptides and small molecules. The nanopores of the npMNA allow for storage of the pharmaceutical compounds. The npMNA is incorporated into a patch. The drug containing npMNA-patches being developed will present numerous advantages over existing technologies: safe, reliable and painfree drug administration, easy to use, possibility of self-administration, high patient comfort.
Company size
1-10 employees
Accessibility
Wheelchair-accessible entrance